Literature DB >> 6136552

Sustained levodopa therapy in tardive dyskinesia.

R J Hardie, A J Lees, G M Stern.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136552      PMCID: PMC1027496          DOI: 10.1136/jnnp.46.7.685

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

Review 1.  The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.

Authors:  C D Marsden; P Jenner
Journal:  Psychol Med       Date:  1980-02       Impact factor: 7.723

2.  L-DOPA reversal of hyperdopaminergic behaviour.

Authors:  C Ezrin-Waters; P Seeman
Journal:  Life Sci       Date:  1978-03       Impact factor: 5.037

3.  Paradoxical response to dopamine agonists in tardive dyskinesia.

Authors:  B J Carroll; G C Curtis; E Kokmen
Journal:  Am J Psychiatry       Date:  1977-07       Impact factor: 18.112

4.  Levodopa and receptor sensitivity modification in tardive dyskinesia.

Authors:  D E Casey; J Gerlach; N Bjørndal
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  4 in total
  1 in total

1.  Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors:  R J Hardie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.